Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer, Express Scripts Clash Over Biosimilar Formulary Placement

May 14 2019

• By Brenda Sandburg

medical-collage

Related Content

Pfizer v. J&J Sets Stage For Biosimilar Showdown Over Exclusive Contracts

Sep 21 2017

No More Rebates: HHS Proposed Rule Revises Anti-Kickback Safe Harbor

Feb 01 2019

Pfizer Wants FDA To Stop Sponsor Promos From Implying Biosimilars Are Inferior

Aug 28 2018

House Judiciary Committee Advances Four Drug Pricing Bills, Although Changes Are Still Likely

Apr 30 2019

HHS Rebate Reform: An Air Of Inevitability In Stakeholder Comments

Apr 22 2019

Amgen Resolves Repatha Access Kerfuffle With Express Scripts

May 13 2019

FTC Would Get Green Light To Go After Patent Thickets Under Bipartisan Senate Bill

May 07 2019

Related Companies

Pfizer Inc.

Express Scripts Holding Company

Amgen, Inc.

Johnson & Johnson

Additional Topics

United States Market Access Biosimilars Commercial Policy Pricing Debate BioPharmaceutical

More from Market Access

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window